Mechanistically, the BTLA-HVEM interaction may reinforce tumor progression through multiple channels, including by limiting effector T cell-mediated cytotoxicity, enhancing Treg stability and function, and potentially engaging reverse signaling in HVEM-expressing tumor cells to promote their survival or resistance to apoptosis [32,86,87]. This evidence concerns the gene TNFRSF14 and neoplasm.